Study aims to see if patient diaries match insurance data
NCT ID NCT02893059
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to see how accurately patients report their own medication and healthcare use in diaries compared to official health insurance records. It planned to include people with diabetes, arthritis, kidney disease, or prostate cancer. However, the study was withdrawn before enrolling anyone, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Expected to start
-
Dec 2020
An estimate. Start dates often move.
- Expected to finish
-
Sep 2021
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of incident and prevalent cases of patients with chronic disease (diabetes, rheumatoid arthritis, chronic renal failure) or incident cases of prostate cancer, breast cance or colorectal cancer.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * incident and prevalent cases of patients with type I or type II diabetes. arthritis: * incident and prevalent cases of rheumatoid arthritis patients defined according to the ACR-EULAR criteria 2010 (Aletaha D et al, 2010). Renal failure : • incident and prevalent cases of patients with kidney disease stage 3 or 4, transplanted or not. Prostate cancer : • Incident cases of patients with prostate cancer regardless of the stage at diagnosis (positive prostate biopsy). Breast cancer : • Incident cases of patients with breast cancer regardless of the stage at diagnosis (biopsy positive breast). Colorectal cancer : • Incident cases of patients with colorectal cancer regardless of the stage at diagnosis (colonoscopy and polyp biopsy positive). Exclusion Criteria: \- The subject participates in an experimental study of research affecting the therapeutic management of the patient. * The subject is exclusion period determined by a previous study. * The subject is under judicial protection, guardianship or curatorship. * It is not possible to give informed about information * The subject does not read French and is not autonomous filling a questionnaire. * The patient has psychiatric disorders. * The subject is an emergency. * Monitoring between patient visits than 6 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- A scanner in the operating room could show surgeons exactly where prostate cancer remains
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Gut bacteria may hold clues to why some cancer treatments work better